Allergic Bronchopulmonary Aspergillosis Panel II
Use
The Allergic Bronchopulmonary Aspergillosis Panel II aids in diagnosing allergic bronchopulmonary aspergillosis, a hypersensitivity reaction that can occur in some individuals with asthma or cystic fibrosis. The condition is characterized by an exaggerated immune response to Aspergillus fumigatus, a common fungus found in the environment. Identifying and managing this condition is critical in preventing further pulmonary deterioration and improving the quality of life in affected individuals. The panel measures levels of total IgE, specific IgE and IgG antibodies to Aspergillus fumigatus, and assesses the presence of immunodiffusion patterns, providing a comprehensive overview of the patient's immune response.
Special Instructions
Not provided.
Limitations
The interpretation of results should be performed with caution, considering that elevated IgE levels can also be indicative of other allergic conditions or parasitic infections. Results from the Ouchterlony Gel Immunodiffusion test require careful interpretation as false positives can occur. Additionally, clinical correlation is necessary, and results should be considered alongside clinical findings and other diagnostic procedures. Variations in specimens or improper handling can also affect results, emphasizing the need for strict adherence to specimen collection and handling protocols.
Methodology
Immunoassay (FEIA)
Biomarkers
LOINC Codes
- 6025-1 - A fumgtus IgE Qn
- 102153-4 - A fumgtus IgE RAST
- 26954-8 - A fumgtus IgG Ser-mCnc
- 23821-2 - A fumgtus Ab Ser Ql ID
Result Turnaround Time
5-9 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1.5 mL
Minimum Volume
1 mL
Container
Plastic vial
Collection Instructions
Centrifuge and aliquot 1.5 mL of serum into a plastic vial. Send refrigerate.
Causes for Rejection
Lipemia
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 28 days |
| Frozen | 365 days |